Besides allergic reactions, therapy with ASP is associated with coagulopathy due to a decrease in almost all proteins responsible for coagulation and anticoagulation, but antithrombin III (AT III) is affected to the greatest extent [3]. The gene discussed is SERPINC1; the disease is allergic disease.